Articles

Podcasts

Videos

Dermatology

The HCPLive dermatology page is a resource for medical news and expert insights on skin disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for dermatologic conditions, and more.

Promising 2-year data for the IL-17 targeting biologic were recently presented at AAD 2022.

FDA Decision on UCB's Bimekizumab for Plaque Psoriasis Delayed by CRL

Exact triggers in acute urticaria and chronic urticaria are largely unknown, with the success of identifying causes of AU varying between 21-68%.

Infections Deemed Most Common Trigger of Pediatric Urticaria

Previous research has suggested that psoriasis could affect both fecundity and fertility, leading to spontaneous abortion and ectopic pregnancy.

Pregnant Women with Psoriasis at Increased Risk of Ectopic Pregnancy

The current registered dosing of the therapy is 30 mg twice daily, but the analyzed dosage of 20 mg has not yet been approved.

Apremilast Monotherapy Effective in Moderate to Severe Plaque Psoriasis

Similarly, patients affected by alopecia areata had higher odds of developing psoriasis.

Patients with Psoriasis Have Higher Odds of Developing Alopecia Areata

New 5-year data shows psoriasis improvement was similar among patients with and without metabolic syndrome, regardless of which dose they received.

Tildrakizumab Effective in Patients with Psoriasis and Metabolic Syndrome

Dr. McKinley-Grant details the new health movement that aims to stop the cycle of suffering for people of color living with psoriatic disease.

How Determi-Nation Promotes Diversity in Psoriasis Research and Treatment

However, comorbidity risk was believed to be substantially different between the two diseases.

Overlapping Comorbidities Observed for Palmoplantar Pustulosis and Psoriasis Vulgaris

Elapsed time following diagnosis, naïve biologic therapy status and previous use of only 1 biologic were associated with higher persistence rates.

Predictors of Secukinumab Persistence Identified in Patients with Psoriasis

New 108 week data found that treatment with the biologic resulted in significant skin clearance in pediatric patients with psoriasis.

Long-Term Ixekizumab Safe, Effective in Pediatric Psoriasis

The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.